Cite
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients.
MLA
Baranzini, Sergio E., et al. “Prognostic Biomarkers of IFNb Therapy in Multiple Sclerosis Patients.” Multiple Sclerosis Journal, vol. 21, no. 7, June 2015, pp. 894–904. EBSCOhost, https://doi.org/10.1177/1352458514555786.
APA
Baranzini, S. E., Madireddy, L. R., Cromer, A., D, A. M., Lehr, L., Beelke, M., Farmer, P., Battaglini, M., Caillier, S. J., Stromillo, M. L., De Stefano, N., Monnet, E., & Cree, B. A. (2015). Prognostic biomarkers of IFNb therapy in multiple sclerosis patients. Multiple Sclerosis Journal, 21(7), 894–904. https://doi.org/10.1177/1352458514555786
Chicago
Baranzini, Sergio E, Lohith R Madireddy, Anne Cromer, Antonio, Mauro D, Lorenz Lehr, Manolo Beelke, Pierre Farmer, et al. 2015. “Prognostic Biomarkers of IFNb Therapy in Multiple Sclerosis Patients.” Multiple Sclerosis Journal 21 (7): 894–904. doi:10.1177/1352458514555786.